Approval · Notice of Compliance 13964 · 2012

DIACOMIT: Notice of Compliance 13964

Issued December 21, 2012

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 13964
Date: December 21, 2012
Company: Biocodex SasGentilly, Cedex, France
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: New Active Substance (NAS)
Therapeutic class: Antiepileptic

Products in this notice

Brand	DIN	Status today
DIACOMIT	02398958	Marketed
DIACOMIT	02398966	Marketed
DIACOMIT	02398974	Marketed
DIACOMIT	02398982	Dormant

Medicinal ingredients

STIRIPENTOL 250 MG per CAP
STIRIPENTOL 500 MG per CAP
STIRIPENTOL 250 MG per PCK
STIRIPENTOL 500 MG per PCK